The SARS-CoV-2 spike protein: balancing stability and infectivity.

Berger, Imre; Schaffitzel, Christiane

Berger, Imre; Schaffitzel, Christiane.

Berger I; School of Biochemistry, University of Bristol, 1 Tankard's Close, Bristol, BS8 1TD, UK.
Schaffitzel C; Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol, BS8 1TQ, UK.

Cell Res ; 30(12): 1059-1060, 2020 12.

Article in English | MEDLINE | ID: covidwho-1387273

Subject(s)

SARS-CoV-2/metabolism; Spike Glycoprotein, Coronavirus/metabolism; Angiotensin-Converting Enzyme 2/metabolism; COVID-19/pathology; COVID-19/virology; Humans; Mutation; Protein Binding; Protein Domains; Protein Stability; Protein Structure, Tertiary; SARS-CoV-2/isolation & purification; Spike Glycoprotein, Coronavirus/chemistry; Spike Glycoprotein, Coronavirus/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / SARS-CoV-2 Limits: Humans Language: English Journal: Cell Res Year: 2020 Document Type: Article Affiliation country: S41422-020-00430-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google